[1] Oronsky B, Ma PC, Morgensztern D, et al.Nothing but net: a review of neuroendocrine tumors and carcinomas[J]. Neoplasia, 2017, 19(12): 991-1002. [2] Pointer KB, Ko HC, Brower JV, et al.Small cell carcinoma of the head and neck: an analysis of the national cancer database[J]. Oral Oncol, 2017, 69(1): 92-98. [3] Mandish SF, Gaskins JT, Yusuf MB, et al.Extrapulmonary small cell carcinoma: prognostic factors, patterns of care, and overall survival[J]. Eur J Surg Oncol, 2020, 46(9): 1596-1604. [4] Wakasaki T, Yasumatsu R, Masuda M, et al.Small cell carcinoma in the head and neck[J]. Ann Otol Rhinol Laryngol, 2019, 128(11): 1006-1012. [5] Ferlito A.Diagnosis and treatment of small cell carcinoma of the larynx: a critical review[J]. Ann Otol Rhinol Laryngol, 1986, 95(6 Pt 1): 590-600. [6] 李红, 林香桃, 龙绮. 鼻咽部小细胞神经内分泌癌临床病理分析[J]. 海南医学, 2017, 28(24): 4108-4109. [7] Zhan KY, Din HA, Muus JS, et al.Predictors of survival in parotid small cell carcinoma: a study of 344 cases[J]. Laryngoscope, 2016, 126(9): 2036-2040. [8] 程宗生, 金银环. 原发性腮腺神经内分泌小细胞癌:附1例报道并文献复习[J]. 口腔疾病防治, 2017, 25(12): 803-805. [9] 周福亭,李宁毅,卜令学.颌面部小细胞癌的临床与病理-附3例报告[J]. 中华老年口腔医学杂志, 2007, 5(1): 43-45. [10] Görner M, Brasch F, Hirnle P, et al.Multimodality treatment for poorly differentiated neuroendocrine head and neck carcinomas--a single institution experience[J]. Eur J Cancer Care (Engl), 2013, 22(5): 648-652. [11] Bean MB, Liu Y, Jiang R, et al.Small cell and squamous cell carcinomas of the head and neck: comparing incidence and survival trends based on surveillance, epidemiology, and end results (SEER) data[J]. Oncologist, 2019, 24(12): 1562-1569. [12] 李正江, 李会政, 刘文胜, 等. 头颈部小细胞神经内分泌癌的临床分析[J].中华医学杂志, 2008, 88(46): 3275-3278. [13] Bellizzi AM.Immunohistochemistry in the diagnosis and classification of neuroendocrine neoplasms: what can brown do for you?[J]. Hum Pathol, 2020, 96: 8-33. [14] 童贤周, 黄文斌, 王劲松, 等. 肺外神经内分泌肿瘤中甲状腺转录因子-1的表达[J]. 临床与实验病理学杂志, 2009, 25(5): 507-509. [15] Lamarca A, Walter T, Pavel M, et al.Design and validation of the GI-NEC score to prognosticate overall survival in patients with high-grade gastrointestinal neuroendocrine carcinomas[J]. J Natl Cancer Inst, 2017, 109(5): 1-9. [16] Benzerdjeb N, Traverse-Glehen A, Philouze P, et al.Poorly differentiated neuroendocrine carcinoma of the head and neck: human papillomavirus tumour status/p16 status and impact on overall survival[J]. Histopathology, 2020, 76(4): 581-591. [17] Albores-Saavedra J, Batich K, Chable-Montero F, et al.Merkel cell carcinoma demographics, morphology, and survival based on 3870 cases: a population based study[J]. J Cutan Pathol, 2010, 37(1): 20-27. [18] Duncavage EJ, Le BM, Wang D, et al.Merkel cell polyomavirus: a specific marker for Merkel cell carcinoma in histologically similar tumors[J]. Am J Surg Pathol, 2009, 33(12): 1771-1777. [19] Chan JK, Suster S, Wenig BM, et al.Cytokeratin 20 immunoreactivity distinguishes Merkel cell (primary cutaneous neuroendocrine) carcinomas and salivary gland small cell carcinomas from small cell carcinomas of various sites[J]. Am J Surg Pathol, 1997, 21(2): 226-234. [20] Tseng CH, Chen CH, Chen CY, et al.Merkel-type oral small cell neuroendocrine carcinoma as second malignancy of tongue[J]. J Dent Sci, 2021, 16(4): 1290-1292. [21] Lewis JS Jr, Duncavage E, Klonowski PW.Oral cavity neuroendocrine carcinoma: a comparison study with cutaneous Merkel cell carcinoma and other mucosal head and neck neuroendocrine carcinomas[J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2010, 110(2): 209-217. [22] Brennan SM, Gregory DL, Stillie A, et al.Should extrapulmonary small cell cancer be managed like small cell lung cancer?[J]. Cancer, 2010, 116(4): 888-895. [23] Galanis E, Frytak S, Lloyd RV.Extrapulmonary small cell carcinoma[J]. Cancer, 1997, 79(9): 1729-1736. [24] Hosokawa S, Takahashi G, Baba S, et al.Small cell neuroendocrine carcinomas arising in the head and neck region[J]. J Oral Maxillofac Surg, 2016, 74(5): 1091-1095. [25] Yu CX, Yibulayin F, Feng L, et al.Clinicopathological characteristics, treatment and prognosis of head & neck small cell carcinoma: a SEER population-based study[J]. BMC Cancer, 2020, 20(1): 1208-1217. |